Hormones: all 321 studies that test it
Page 3 of 4. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- Adipokine Profile in Patients With Cushing's Disease on Pasireotide TreatmentCompletedNCT03080181Phase 4
- Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal VasculitisStatus unknownNCT03066869Phase 4
- Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose ChallengeCompletedNCT03061227Not applicable
- Pasireotide in Hyperinsulinemic HypoglycemiaWithdrawnNCT03053284Phase 2
- Prevention of Postoperative Pancreatic Fistula by SomatostatinCompletedNCT03000946Phase 3
- Influence of FSH/LH Ratio in Controlled Ovarian StimulationCompletedNCT02994550Early Phase 1
- Availability Study of ACTH to Treat Children SRNS/SDNSStatus unknownNCT02972346Not applicable
- ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)CompletedNCT02931175Phase 2
- ACTHAR Therapy for Central Nervous System SarcoidosisWithdrawnNCT02920710Phase 4
- The Effect of Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF)Status unknownNCT02882347Phase 3
- Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 DiabetesWithdrawnNCT02846857Phase 2
- Metabolic Consequences of Gastrointestinal SurgeryTerminatedNCT02836353Not applicable
- Mass Spectrometry Based Cutoffs for Cortisol After Stimulation TestsCompletedNCT02818660Not applicable
- To Determine Tolerability to Glucagon Infusion in Obese SubjectsActive, not recruitingNCT02817659Phase 1
- Evaluation of the Effectiveness and Tolerance of Tetracosactide Synacthen® in the Treatment of Post Dural Puncture Headaches (ESYBRECHE)TerminatedNCT02813655Phase 2
- Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular CarcinomaCompletedNCT02799212Phase 3
- SOM230 Ectopic ACTH-producing TumorsWithdrawnNCT02780882Phase 2
- Pasireotide Treatment for Neuroendocrine TumorWithdrawnNCT02779257Phase 4
- Acthar SLE (Systemic Lupus Erythematosus)WithdrawnNCT02779153Phase 4
- Vasoactive Drugs in Real World PracticeCompletedNCT02757703Phase 4
- In Vivo Assessment of Cellular Metabolism in HumansCompletedNCT02748369Phase 1
- Assessment of Intranasal Glucagon on Endogenous Glucose ProductionCompletedNCT02740829Phase 1
- Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian ResponseStatus unknownNCT02736591Phase 3
- Reduction by Pasireotide of the Effluent Volume in High-output Enterostomy in Patients Refractory to Usual Medical TreatmentCompletedNCT02713776Phase 2
- Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATETStatus unknownNCT02631616Phase 1
- Pasireotide for the Treatment of Gastrointestinal Angiodysplasia in Endoscopic Treatment FailureCompletedNCT02622906Phase 2
- Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating NeuropathyWithdrawnNCT02574962Phase 2
- The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive ImpairmentCompletedNCT02553603Phase 1
- Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 DiabetesWithdrawnNCT02490098Phase 2
- Safety and Efficacy of Acthar Gel in an Outpatient Dialysis PopulationTerminatedNCT02486744Phase 1
- Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon ClearanceCompletedNCT02475421Not applicable
- Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for HypoglycemiaCompletedNCT02459938Phase 1
- Pancreatic Perfusion Using Secretin and MRIStatus unknownNCT02458118Phase 1/2
- Addition of H.P. Acthar Gel to Treatment Regimen of Patients With Rheumatoid ArthritisStatus unknownNCT02434757Not applicable
- Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 DiabetesCompletedNCT02416765Phase 2
- Acthar for Treatment of Post-transplant FSGSWithdrawnNCT02399462Phase 4
- Acthar on Proteinuria in IgA Nephropathy PatientsWithdrawnNCT02382523Phase 4
- ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label TrialStatus unknownNCT02348905Phase 2/3
- Comparison Between Laparoscopic Ovarian Diathermy and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.Status unknownNCT02304536Phase 3
- Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.CompletedNCT02304107Phase 3
- Outcome of Three Controlled Ovarian Hyperstimulation Protocols in Poor Responding Infertility PatientsCompletedNCT02293668Not applicable
- FSH in Azoospermic MenWithdrawnNCT02275169Phase 4
- Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 DiabetesStatus unknownNCT02232971Phase 4
- Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)Status unknownNCT02188017Phase 4
- ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot StudyStatus unknownNCT02155803Phase 2/3
- Safety and Efficacy Study of Acthar in Subjects With ARDSWithdrawnNCT02113735Phase 2
- Evaluation of Neuroinflammation in Children With Infantile SpasmsCompletedNCT02092883Phase 4
- Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)CompletedNCT02086227Phase 1
- ACTH Treatment of APOL1- Associated NephropathyWithdrawnNCT02006849Not applicable
- Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic NeuritisCompletedNCT01987167Early Phase 1
- Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic ArthritisStatus unknownNCT01939132Phase 4
- ACTHAR GEL in Patients With Membranous (Class V) Lupus NephritisWithdrawnNCT01926054Phase 4
- Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon DosagesCompletedNCT01916265Phase 1
- Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node DissectionCompletedNCT01914692Phase 4
- Comprehensive Analysis of Relapse in Multiple SclerosisStatus unknownNCT01906684Not applicable
- Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS RelapsesStatus unknownNCT01900093Not applicable
- Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping SyndromeCompletedNCT01895296Phase 2
- Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS ExacerbationsCompletedNCT01888354Phase 4
- Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac SurgeryCompletedNCT01839812Phase 1
- A Trial of Neuroprotection With ACTH in Acute Optic NeuritisTerminatedNCT01838174Phase 4
- Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 DiabetesWithdrawnNCT01828125Phase 2
- A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic MigrainesCompletedNCT01813591Phase 2
- Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory HormonesStatus unknownNCT01795235Not applicable
- Efficacy and Safety of FSH-GEX™ in Comparison With 150 IU Gonal-f®CompletedNCT01794208Phase 2
- Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing StudyCompletedNCT01783301Phase 4
- Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus ErythematosusCompletedNCT01769937Phase 4
- Effect of Glucagon on Uterine Contractility at the Time of Embryo Transfer in in Vitro FertilizationWithdrawnNCT01674283Phase 4
- Stress Biomarkers:Attaching Biological Meaning to Field Friendly Salivary MeasuresCompletedNCT01673087Phase 1
- Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate CancerCompletedNCT01646684Phase 1
- Pasireotide Therapy in Patients With Nelson's SyndromeTerminatedNCT01617733Phase 2
- A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy VolunteersCompletedNCT01578928Phase 1
- Basal Androgens and LH Needing for Ovarian Stimulation for in Vitro FertilizationCompletedNCT01563809Phase 3
- Multiple Dose FSH-GEX(TM) in Healthy VolunteersCompletedNCT01477073Phase 1
- Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic MetastasesCompletedNCT01469572Phase 1
- Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy VolunteersCompletedNCT01452217Phase 1
- Effects of Somatostatin on Post-endoscopic Portal Hemodynamic in Cirrhotic Patients With Esophageal Gastric VaricesStatus unknownNCT01426087Not applicable
- Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and StimulationActive, not recruitingNCT01421797Not applicable
- Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung CancerStatus unknownNCT01417806Phase 2
- Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle TrialCompletedNCT01372644Phase 1
- Prevention of West Syndrome With Low-dose Adrenocorticotropin Hormone (ACTH)TerminatedNCT01367964Not applicable
- Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)CompletedNCT01364415Phase 1
- Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast CancerCompletedNCT01356862Phase 2
- Single Dose FSH-GEX™ in Healthy VolunteersCompletedNCT01354886Phase 1
- SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple MyelomaWithdrawnNCT01329289Phase 2
- A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal BleedingCompletedNCT01267669Not applicable
- IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor EverolimusWithdrawnNCT01234974Phase 2
- Acute Regulation of Intestinal and Hepatic Lipoprotein Production by GlucagonCompletedNCT01155206Phase 4
- A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy VolunteersCompletedNCT01134848Phase 4
- Secretin-enhanced Magnetic Resonance Imaging (S-MRI) for Pancreatic Cancer DetectionWithdrawnNCT01094626Not applicable
- A Dose Escalation Study of Long-acting ACTH Gel in Membranous NephropathyCompletedNCT01093157Phase 1/2
- Identifying the Effect of Somatostatin Treatment in Early Postoperative Simple Small Bowel ObstructionCompletedNCT01082627Phase 4
- Peripheral Metabolic Effects of SomatostatinCompletedNCT01062529Not applicable
- Efficacy of Administration of Somatostatin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) PancreatitisStatus unknownNCT01060826Phase 3
- New Chemotherapy Regimen in the Treatment of Advanced Gallbladder CarcinomaCompletedNCT01053390Phase 3
- Pulse ACTH vs. MP for MSCompletedNCT01049451Phase 1
- Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)CompletedNCT01028287Phase 4
- Prospective Study Evaluating the Effect of Repository Corticotropin in the Treatment of Various Nephrotic SyndromesCompletedNCT01021540Phase 4
- Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)WithdrawnNCT00986960Phase 2
- Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) MethylprednisoloneTerminatedNCT00947895Phase 2/3
- Glucagon Modulation of Ghrelin SecretionStatus unknownNCT00929812Phase 3